Cargando…
Towards an Architecture to Guarantee Both Data Privacy and Utility in the First Phases of Digital Clinical Trials
In the era of the Internet of Things (IoT), drug developers can potentially access a wealth of real-world, participant-generated data that enable better insights and streamlined clinical trial processes. Protection of confidential data is of primary interest when it comes to health data, as medical...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308650/ https://www.ncbi.nlm.nih.gov/pubmed/30487435 http://dx.doi.org/10.3390/s18124175 |